The cancer diagnostic company, Pacific Edge, has seen its share price rise by a quarter this morning, after gaining permission to market its products to United States war veterans.
The cancer diagnostic company, Pacific Edge, has seen its share price rise by a quarter this morning, after gaining permission to market its products to United States war veterans.